Effects of Tea Catechins on Cardiac Allografts

[1]  R. Morishita,et al.  Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[2]  Paul Aurora,et al.  Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  L. Gatto,et al.  Green tea extract prolongs allograft survival as an adjunctive therapy along with low dose cyclosporine A. , 2009, The Journal of surgical research.

[4]  A. Koch,et al.  Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production , 2008, Proceedings of the National Academy of Sciences.

[5]  Dongmin Liu,et al.  Green tea catechins and cardiovascular health: an update. , 2008, Current medicinal chemistry.

[6]  F. Villarreal,et al.  Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury. , 2008, American journal of physiology. Heart and circulatory physiology.

[7]  G. Kuttan,et al.  (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-α in LPS-stimulated macrophages , 2008, Innate immunity.

[8]  S. Davidge,et al.  Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells. , 2008, Life sciences.

[9]  Timothy J. Burroughs,et al.  Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. , 2008, European journal of pharmacology.

[10]  Q. Wang,et al.  Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis. , 2007, The Journal of nutritional biochemistry.

[11]  Shun-Fa Yang,et al.  Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[12]  T. Ha,et al.  Epigallocatechin-3-O-Gallate Inhibits the Angiotensin II-Induced Adhesion Molecule Expression in Human Umbilical Vein Endothelial Cell Via Inhibition of MAPK Pathways , 2007, Cellular Physiology and Biochemistry.

[13]  J. Um,et al.  Epigallocatechin-3-gallate suppresses NF-κB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells , 2007 .

[14]  R. Béliveau,et al.  Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg. , 2007, Leukemia research.

[15]  M. Isobe,et al.  Tea catechins attenuate chronic ventricular remodeling after myocardial ischemia in rats. , 2007, Journal of molecular and cellular cardiology.

[16]  M. Isobe,et al.  Tea catechins improve left ventricular dysfunction, suppress myocardial inflammation and fibrosis, and alter cytokine expression in rat autoimmune myocarditis , 2007, European journal of heart failure.

[17]  A. Itai,et al.  Inhibition of NF-κB improves left ventricular remodeling and cardiac dysfunction after myocardial infarction , 2007 .

[18]  Mi Hee Lee,et al.  Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-kappaB down-modulation. , 2006, Biochemical and biophysical research communications.

[19]  M. Isobe,et al.  Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts. , 2006, Cardiovascular research.

[20]  J. Chung,et al.  The effects of epigallocatechin-3-gallate on extracellular matrix metabolism. , 2005, Journal of dermatological science.

[21]  T. Murohara,et al.  Mechanisms of the Inhibitory Effect of Epigallocatechin-3-Gallate on Cultured Human Vascular Smooth Muscle Cell Invasion , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[22]  M. Isobe,et al.  Dietary consumption of green tea catechins attenuate hyperlipidaemia-induced atherosclerosis and systemic organ damage in mice , 2005, Acta cardiologica.

[23]  M. Isobe,et al.  Catechins attenuate myocardial cell infiltration and fibrosis but do not prolong graft survival in murine cardiac allografts. , 2005, Transplantation proceedings.

[24]  S. Hayakawa,et al.  Catechins prevents substance P-induced hyperactive bladder in rats via the downregulation of ICAM and ROS , 2004, Neuroscience Letters.

[25]  A. Itai,et al.  Inhibition of IκB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury , 2004 .

[26]  Nagi B. Kumar,et al.  Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. , 2004, Nutrition reviews.

[27]  C. Bartsch,et al.  The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. , 2004, Biochemical and biophysical research communications.

[28]  Timothy J. Burroughs,et al.  Epigallocatechin, a Green Tea Polyphenol, Attenuates Myocardial Ischemia Reperfusion Injury in Rats , 2004, Molecular medicine.

[29]  E. Tuzcu,et al.  Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. , 2003, The New England journal of medicine.

[30]  P. Libby,et al.  Tumor Necrosis Factor Receptor ‐1 and ‐2 Double Deficiency Reduces Graft Arterial Disease in Murine Cardiac Allografts , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  R. Wilensky,et al.  Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction. , 2003, The American journal of cardiology.

[32]  M. Isobe,et al.  Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway. , 2003, Cardiovascular research.

[33]  X. Cheng,et al.  Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. , 2003, Atherosclerosis.

[34]  Y. Naito,et al.  Inhibitory effects of catechins on neutrophil-dependent gastric inflammation , 2002, Redox report : communications in free radical research.

[35]  H. Mukhtar,et al.  Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells. , 2002, Archives of biochemistry and biophysics.

[36]  A. Albini,et al.  Anti-Invasive Effects of Green Tea Polyphenol EpiGalloCatechin-3-Gallate (EGCG), a Natural Inhibitor of Metallo and Serine Proteases , 2002, Biological chemistry.

[37]  M. Aoki,et al.  cis Element Decoy Against Nuclear Factor-&kgr;B Attenuates Development of Experimental Autoimmune Myocarditis in Rats , 2001, Circulation research.

[38]  P. Yaqoob,et al.  The effects of phenolic components of tea on the production of pro- and anti-inflammatory cytokines by human leukocytes in vitro. , 2001, Cytokine.

[39]  Y. Kaneda,et al.  Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts , 2000, Gene Therapy.

[40]  C. Oakley,et al.  Myocarditis, pericarditis and other pericardial diseases , 2000, Heart.

[41]  G. Williamson,et al.  Dietary intake and bioavailability of polyphenols. , 2000, The Journal of nutrition.

[42]  G. Beecher,et al.  Analysis of tea polyphenols. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[43]  M. Isobe,et al.  Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[44]  Jen-kun Lin,et al.  (−)-Epigallocatechin-3-gallate Blocks the Induction of Nitric Oxide Synthase by Down-Regulating Lipopolysaccharide-Induced Activity of Transcription Factor Nuclear Factor-κB , 1997 .

[45]  M. Aoki,et al.  Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide , 1997, Nature Medicine.

[46]  T. Ogihara,et al.  In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction , 1997, Nature Medicine.

[47]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.